» Articles » PMID: 27873317

The B-cell-activating Factor Signalling Pathway is Associated with Helicobacter Pylori Independence in Gastric Mucosa-associated Lymphoid Tissue Lymphoma Without T(11;18)(q21;q21)

Overview
Journal J Pathol
Specialty Pathology
Date 2016 Nov 23
PMID 27873317
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

We previously reported that activation of the B-cell-activating factor (BAFF) pathway upregulates nuclear factor-κB (NF-κB) and induces BCL3 and BCL10 nuclear translocation in Helicobacter pylori (HP)-independent gastric diffuse large B-cell lymphoma (DLBCL) tumours with evidence of mucosa-associated lymphoid tissue (MALT). However, the significance of BAFF expression in HP independence of gastric low-grade MALT lymphomas without t(11;18)(q21;q21) remains unexplored. Sixty-four patients who underwent successful HP eradication for localized HP-positive gastric MALT lymphomas without t(11;18)(q21;q21) were studied. BAFF expression was significantly higher in the HP-independent group than in the HP-dependent group [22/26 (84.6%) versus 8/38 (21.1%); p < 0.001]. Similarly, BAFF receptor (BAFF-R) expression (p = 0.004) and nuclear BCL3 (p = 0.004), BCL10 (p < 0.001), NF-κB (p65) (p = 0.001) and NF-κB (p52) (p = 0.005) expression were closely correlated with the HP independence of these tumours. Moreover, BAFF overexpression was significantly associated with BAFF-R expression and nuclear BCL3, BCL10, NF-κB (p65) and NF-κB (p52) expression. These findings were further validated in an independent cohort, including 40 HP-dependent cases and 18 HP-independent cases of gastric MALT lymphoma without t(11;18)(q21;q21). The biological significance of BAFF signalling in t(11;18)(q21;q21)-negative lymphoma cells was further studied in two types of lymphoma B cell: OCI-Ly3 [non-germinal centre B-cell origin DLBCL without t(11;18)(q21;q21) cell line] and MA-1 [t(14;18)(q32;q21)/IGH-MALT1-positive DLBCL cell line]. In both cell lines, we found that BAFF activated the canonical NF-κB and AKT pathways, and induced the formation of BCL10-BCL3 complexes, which translocated to the nucleus. BCL10 and BCL3 nuclear translocation and NF-κB (p65) transactivation were inhibited by either LY294002 or by silencing BCL3 or BCL10 with small interfering RNA. BAFF also activated non-canonical NF-κB pathways (p52) through tumour necrosis factor receptor-associated factor 3 degradation, NF-κB-inducing kinase accumulation, inhibitor of κB kinase (IKK) α/β phosphorylation and NF-κB p100 processing in both cell lines. Our data indicate that the autocrine BAFF signal transduction pathway contributes to HP independence in gastric MALT lymphomas without the t(11;18)(q21;q21) translocation. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Citing Articles

Cooperative participation of CagA and NFATc1 in the pathogenesis of antibiotics-responsive gastric MALT lymphoma.

Tsai H, Yeh K, Lin C, Wu M, Liou J, Hsu P Cancer Cell Int. 2024; 24(1):383.

PMID: 39558403 PMC: 11575159. DOI: 10.1186/s12935-024-03552-6.


Clinical relevance of molecular aspects in extranodal marginal zone lymphoma: a critical appraisal.

Raderer M, Kiesewetter B, Du M Ther Adv Med Oncol. 2023; 15:17588359231183565.

PMID: 37389189 PMC: 10302523. DOI: 10.1177/17588359231183565.


MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer.

Kuo S, Wei M, Lee Y, Lin J, Yang W, Yang S Cell Oncol (Dordr). 2023; 46(5):1213-1234.

PMID: 37166744 DOI: 10.1007/s13402-023-00805-w.


First-line antibiotic treatment in patients with localized extragastric mucosa-associated lymphoid tissue lymphoma.

Yao M, Liao S, Lin C, Wang C, Ma W, Wei Y EJHaem. 2023; 4(1):55-66.

PMID: 36819144 PMC: 9928665. DOI: 10.1002/jha2.608.


Current Status of the Spectrum and Therapeutics of -Negative Mucosa-Associated Lymphoid Tissue Lymphoma.

Kuo S, Yeh K, Lin C, Liou J, Wu M, Chen L Cancers (Basel). 2022; 14(4).

PMID: 35205754 PMC: 8869919. DOI: 10.3390/cancers14041005.